Zhengping Zhuang

发表

Targeting selenoprotein H in the nucleolus suppresses tumors and metastases by Isovalerylspiramycin I

M. Gilbert, T. Westlake, M. Aladjem, 2022, Journal of experimental & clinical cancer research : CR.

Isovalerylspiramycin I suppresses non-small cell lung carcinoma growth through ROS-mediated inhibition of PI3K/AKT signaling pathway

S. Shan, T. Ren, Jingyuan Zhang, 2022, International journal of biological sciences.

Ocular manifestations of HIF-2 α paraganglioma-somatostatinomapolycythemia syndrome

Matthew W. Wilson, E. Chew, A. Pappo, 2014 .

Laser Capture Microdissection

L. Liotta, M. Emmert-Buck, R. Bonner, 1996, Science.

Targeting PP2A for cancer therapeutic modulation

Zhengping Zhuang, Jared S Rosenblum, H. Ronk, 2022, Cancer biology & medicine.

Acute worsening of CADASIL in a patient with COVID-19 infection: illustrative case

J. Smirniotopoulos, J. Heiss, A. Bluestone, 2022, Journal of neurosurgery. Case lessons.

A 13-Year-Old Male With Left Eye Swelling.

R. Lonser, K. Pacak, A. Malik, 2022, Pediatrics.

Endogenous Retroviral Elements in Human Development and Central Nervous System Embryonal Tumors

M. Gilbert, Zhengping Zhuang, Jared S Rosenblum, 2021, Journal of Personalized Medicine.

Carrimycin, a first in-class anti-cancer agent, targets selenoprotein H to induce nucleolar oxidative stress and inhibit ribosome biogenesis

Zhengping Zhuang, Danielle D. Dang, Jared S Rosenblum, 2023, Cancer Pathogenesis and Therapy.

A novel splicing site IRP1 somatic mutation in a patient with pheochromocytoma and JAK2V617F positive polycythemia vera: a case report

K. Pacak, Z. Abdullaev, Chunzhang Yang, 2018, BMC Cancer.

Sequential combination of decitabine and idarubicin synergistically enhances anti-leukemia effect followed by demethylating Wnt pathway inhibitor promoters and downregulating Wnt pathway nuclear target

J. Vera, Jie Jin, Z. Ren, 2014, Journal of Translational Medicine.

Clinical research priorities in Renal cell carcinoma

B. Zbar, M. Blute, D. Barrett, 1997, Cancer.

Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma/paraganglioma-polycythemia

U. Shankavaram, M. Merino, A. Elkahloun, 2014, Journal of Molecular Medicine.

A novel EPAS1/HIF2A germline mutation in a congenital polycythemia with paraganglioma

J. Prchal, K. Pacak, F. Lorenzo, 2012, Journal of Molecular Medicine.

“Tumor Treating Fields” delivered via electromagnetic induction have varied effects across glioma cell lines and electric field amplitudes

Nathan H. Williamson, P. Basser, M. Gilbert, 2023, bioRxiv.

Non-invasive in situ visualization of the murine cranial vasculature

R. Knutsen, K. Pacak, D. McGavern, 2022, Cell reports methods.

Small posterior fossa in Chiari I malformation affected families is significantly linked to 1q43-44 and 12q23-24.11 using whole exome sequencing

W. Ho, C. Simpson, Anthony M. Musolf, 2019, European Journal of Human Genetics.

Epigenetic Regulation in Primary CNS Tumors: An Opportunity to Bridge Old and New WHO Classifications

Zhengping Zhuang, J. Rosenblum, Tara T. Doucet-O’Hare, 2023, Cancers.

A protocol for visualization of murine in situ neurovascular interfaces.

R. Knutsen, K. Pacak, D. McGavern, 2023, STAR protocols.

A morphologic and semi-quantitative technique to analyze synthesis and release of specific proteins in cells

J. Gu, J. Gu, Chunzhang Yang, 2014, BMC Cell Biology.

EGFR signaling confers resistance to BET inhibition in hepatocellular carcinoma through stabilizing oncogenic MYC

Shuijun Zhang, J. Qin, Xiaoyan Sun, 2019, Journal of Experimental & Clinical Cancer Research.

The combination of immunotherapy and a glutamine metabolism inhibitor represents an effective therapeutic strategy for advanced and metastatic murine pancreatic adenocarcinoma.

K. Pacak, J. Ženka, J. Chmelař, 2023, International immunopharmacology.

Laser Capture Microdissection

L. Liotta, C. Paweletz, M. Emmert-Buck, 2001, Current protocols in cell biology.

Intratumoral immunotherapy of murine pheochromocytoma shows no age-dependent differences in its efficacy

K. Pacak, J. Ženka, Herui Wang, 2023, Frontiers in Endocrinology.

TP5: A Novel Therapeutic Approach Targeting Aberrant and Hyperactive CDK5/p25 for the Treatment of Colorectal Carcinoma

E. Tabouret, Sharda Yadav, H. Pant, 2023, International journal of molecular sciences.

A novel HIF2A mutation causes dyslipidemia and promotes hepatic lipid accumulation.

K. Pacak, Jiong Yu, H. Cao, 2023, Pharmacological research.

rWTC-MBTA: autologous vaccine prevents metastases via antitumor immune responses

K. Pacak, J. Ženka, Herui Wang, 2023, Journal of Experimental & Clinical Cancer Research.

Limitations on the quantitative determination of telomerase activity by the electrophoretic and ELISA based TRAP assays.

R. Weil, A. Remaley, A. Yang, 2000, Clinica chimica acta; international journal of clinical chemistry.

Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy

Herui Wang, Zhengping Zhuang, Mitchell Sun, 2023, Frontiers in immunology.

Pacak-Zhuang syndrome: a model providing new insights into tumor syndromes.

K. Pacak, Herui Wang, Zhengping Zhuang, 2023, Endocrine-related cancer.

Venous plexus-associated lymphoid hubs support meningeal humoral immunity

M. Clatworthy, D. McGavern, Kieren Allinson, 2023, Journal of Immunology.